Efficacy and Safety of a Fixed-dose Combination of Naratriptan and Naproxen in Acute Treatment of Migraine.
Status:
Withdrawn
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether a fixed-dose combination of naratriptan 2,5
mg + naproxen 500 mg is effective and safe compared each monotherapy for the acute treatment
of migraine.